Apoptosis in cardiovascular remodeling-effect of medication

Cardiovascular Drugs and Therapy

Volumn 15, Issue 6, 2001, Pages 539-545

  DeBlois, Denis ^a   Orlov, Sergei N ^a   Hamet, Pavel ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiotensin II; Apoptosis; Arteries; Heart; Medication

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATRASENTAN; CALCIUM CHANNEL BLOCKING AGENT; DARUSENTAN; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; ENALAPRIL; HYDRALAZINE; LOSARTAN; VALSARTAN;

APOPTOSIS; CELL DEATH; CELL GROWTH; CELL SPECIFICITY; CELL TYPE; CONFERENCE PAPER; DNA CONTENT; DRUG EFFECT; FIBROBLAST; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HUMAN; HYPERPLASIA; HYPERTENSION; NONHUMAN; POPULATION DYNAMICS; PRIORITY JOURNAL;

ANTIHYPERTENSIVE AGENTS; APOPTOSIS; CARDIOVASCULAR DISEASES; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HEART; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, ANGIOTENSIN; VENTRICULAR REMODELING;

EID: 0035714102     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1013723922582     Document Type: Conference Paper

References (74)

1. Apoptosis: Basic mechanisms and implications for cardiovascular disease
2. Myocyte cell death and ventricular remodeling
3. Smooth muscle cell apoptosis during vascular regression in spontaneously hypertensive rats
4. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: Effect of endothelin receptor antagonism
5. Apoptosis in vasculature of spontaneously hypertensive rats: Effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist
6. Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats: Temporal regulation and spatial heterogeneity
7. Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo
8. Losartan-induced apoptosis as a novel mechanism for the prevention of vascular lesion formation after vascular injury
9. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype
10. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell
11. Molecular and cellular mechanism of angiotensin II-mediated apoptosis
12. Physiological aspects of primary hypertension
13. Proliferation and apoptosis in hypertension
14. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes
15. Evidence that human cardiac myocytes divide after myocardial infarction
16. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of angiotensin II
17. Hypertension and atherosclerosis: Cause and effect, or two effects with one unknown cause?
18. The intima. Soil for atherosclerosis and restenosis
19. Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction
20. The role of apoptosis in vascular disease
21. Enhanced DNA synthesis in heart and kidney of newborn spontaneously hypertensive rats
22. Apoptosis in target organs of hypertension
23. Regression of neointimed lesions in the carotif artery of nifedipine-treated SHR and WKY rats: Possible role of apoptosis
24. Altered balance between cell replication and apoptosis in hearts and kidneys of newborn SHR
25. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats
26. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat
27. Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: Effects of AT1 blockade with losartan
28. Long-term ACE inhibition doubles lifespan of hypertensive rats
29. Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis
30. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats
31. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis
32. Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats?
33. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker
34. Enhanced angiotensin II activity in heart failure: Reevaluation of the counterregulatory hypothesis of receptor subtypes
35. Caspase-3 activation and selective induction of apoptosis in noncardiomyocytes by valsartan in spontaneously hypertensive rats
36. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II
37. Bcl-2 protects cells from cytokine-induced nitric oxide-dependent apoptosis
38. Differential induction of apoptosis in Swiss 3T3 cells by nitric oxide and the nitrosonium cation
39. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system
40. In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels
41. An AT2 receptor antagonist prevents the antiproliferative and pro-apoptotic effects of valsartan in non-cardiomyocytes in the SHR heart
42. Vascular smooth muscle cell hyperresponsiveness to growth factors in hypertension
43. Evidence of altered in vivo vascular turnover in SHR and effect of a chronic antihypertensive treatment
44. Workshop: Excess growth and apoptosis: Is hypertension a case of accelerated aging of cardiovascular cells?
45. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells
46. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide
47. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy
48. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension
49. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload
50. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression
51. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats
52. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism
53. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats
54. AT1 and AT2 angiotensin receptor gene expression in human heart failure
55. Differential expression of angiotensin receptor subtypes in the myocardium: A hypothesis
56. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts
57. Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk
58. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure
59. Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II
60. Interaction of mRNAs for angiotensin II type I and type 2 receptors to vascular remodeling in spontaneously hypertensive rats
61. Proapoptotic effects of ANG II in human coronary artery endothelial cells: Role of AT1 receptor and PKC activation
62. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway
63. Beta-adrenergic stimulation causes cardiocyte apoptosis: Influence of tachycardia and hypertrophy
64. Alpha- and beta-adrenergic pathways differentially regulate cell type-specific apoptosis in rat cardiac myocytes
65. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts
66. Beta-adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase
67. Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 in cardiac fibroblasts
68. Oxidative stress-induced apoptosis of endothelial cells
69. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells
70. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression
71. Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1beta
72. Genetic deletion of AT2 receptor antagonizes angiotensin II-induced apoptosis in fibroblasts of the mouse embryo
73. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer
74. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: An in vitro gene transfer study